The U.S. Food and Drug Administration (FDA) made amendments to the emergency use authorizations (EUAs) of the mRNA vaccines. The use of an extra vaccine dose for immunocompromised individuals is allowed in the US.
What is the new FDA advisory all about?
As per the new release, immunocompromised people are eligible to take another shot of the COVID-19 vaccine. However, this is only applicable for the Moderna or Pfizer-BioNTech vaccines. “The country has entered yet another wave of the COVID-19 pandemic. The FDA is especially cognizant that immunocompromised people are particularly at risk for severe disease. After a thorough review of the available data, the FDA determined. This small, vulnerable group may benefit from a third dose,” said Janet Woodcock. Woodcock is the acting commissioner of the FDA.
Can you get the extra vaccine dose?
According to the FDA’s latest release, immunocompromised people can take an additional dose of the COVID-19 vaccine. However, it is specifically for people who are solid organ transplant recipients. Additionally, those who suffer from an equal level of immunocompromised can also get it. However, patients should contact their doctor to discuss monoclonal antibody treatment plans.
Additionally, the Centers for Disease Control and Prevention (CDC) committee will meet on Friday to discuss the finer terms. “Today’s action allows doctors to boost immunity in certain immunocompromised individuals who need extra protection from COVID-19. Fully protected people do not need an additional dose of the COVID-19 vaccine at this time. The FDA is actively engaged in a science-based, rigorous process with our federal partners to consider whether an additional dose in the future is vital,” added Woodcock.
